Protective Effect of Pyrroloquinoline Quinone (PQQ) in Rat Model of Intracerebral Hemorrhage

Cellular and Molecular Neurobiology

Volumn 35, Issue 7, 2015, Pages 921-930

  Lu, Hongjian ^a,b   Shen, Jiabing ^c   Song, Xinjian ^b   Ge, Jianbin ^b   Cai, Rixin ^c   Dai, Aihua ^c   Jiang, Zhongli ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b The Second People's Hospital of Nantong   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

ICH; Neuroprotectant; PQQ; Rat; ROS

Indexed keywords

CASPASE 3; PROTEIN BAX; PROTEIN BCL 2; PYRROLOQUINOLINEQUINONE; REACTIVE OXYGEN METABOLITE; NEUROPROTECTIVE AGENT;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN MITOCHONDRION; BRAIN WATER; CLIMBING; COGNITIVE DEFECT; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HEMISPHERE; LOCOMOTION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPRIOCEPTION; PROTEIN EXPRESSION; RAT; UPREGULATION; VIBRISSA; WESTERN BLOTTING; ANIMAL; CEREBRAL HEMORRHAGE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PQQ COFACTOR; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 84942193350     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-015-0187-5     Document Type: Article

References (43)

1. Aizenman E, Jensen FE, Gallop PM, Rosenberg PA, Tang LH (1994) Further evidence that pyrroloquinoline quinone interacts with the N-methyl-D-aspartate receptor redox site in rat cortical neurons in vitro. Neurosci Lett 168(1–2):189–192
2. Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, Lindley R, Robinson T, Lavados P, Neal B, Hata J, Arima H, Parsons M, Li Y, Heritier S, Li Q, Woodward M, Simes RJ, Davis SM, Chalmers J (2013) Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 368(25):2355–2365
3. Barratt HE, Lanman TA, Carmichael ST (2014) Mouse intracerebral hemorrhage models produce different degrees of initial and delayed damage, axonal sprouting, and recovery. J Cereb Blood Flow Metab 34(9):1463–1471
4. Garcia JH, Wagner S, Liu KF, Hu XJ (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats statistical validation. Stroke 26(4):627–634 discussion 635
5. Hara H, Hiramatsu H, Adachi T (2007) Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity. Neurochem Res 32(3):489–495
6. Hirakawa A, Shimizu K, Fukumitsu H, Furukawa S (2009) Pyrroloquinoline quinone attenuates iNOS gene expression in the injured spinal cord. Biochem Biophys Res Commun 378(2):308–312
7. Hiraku Y, Kawanishi S (1996) NADH-mediated DNA damage induced by a new coenzyme, pyrroloquinoline quinone, in the presence of copper(II) ion. FEBS Lett 393(2–3):317–320
8. Kasahara T, Kato T (2003) Nutritional biochemistry: a new redox-cofactor vitamin for mammals. Nature 422(6934):832
9. Ke K, Li L, Rui Y, Zheng H, Tan X, Xu W, Cao J, Xu J, Cui G, Xu G, Cao M (2013) Increased expression of small heat shock protein alphaB-crystallin after intracerebral hemorrhage in adult rats. J Mol Neurosci 51(1):159–169
10. Krafft PR, McBride DW, Lekic T, Rolland WB, Mansell CE, Ma Q, Tang J, Zhang JH (2014) Correlation between subacute sensorimotor deficits and brain edema in two mouse models of intracerebral hemorrhage. Behav Brain Res 264:151–160
11. Kumar N, Kar A (2014) Pyrroloquinoline quinone ameliorates oxidative stress and lipid peroxidation in the brain of streptozotocin-induced diabetic mice. Can J Physiol Pharmacol 93:1–9
12. Kuramatsu JB, Huttner HB, Schwab S (2013) Advances in the management of intracerebral hemorrhage. J Neural Transm 120(Suppl 1):S35–S41
13. Liu Z, Zhao W, Xu T, Pei D, Peng Y (2010) Alterations of NMDA receptor subunits NR1, NR2A and NR2B mRNA expression and their relationship to apoptosis following transient forebrain ischemia. Brain Res 1361:133–139
14. Mokrushin AA, Pavlinova LI (2013) Effects of the blood components on the AMPA and NMDA synaptic responses in brain slices in the onset of hemorrhagic stroke. Gen Physiol Biophys 32(4):489–504
15. Naito Y, Kumazawa T, Kino I, Suzuki O (1993) Effects of pyrroloquinoline quinone (PQQ) and PQQ-oxazole on DNA synthesis of cultured human fibroblasts. Life Sci 52(24):1909–1915
16. Nakano M, Suzuki H, Imamura T, Lau A, Lynch B (2013) Genotoxicity of pyrroloquinoline quinone (PQQ) disodium salt (BioPQQ). Regul Toxicol Pharmacol 67(2):189–197
17. Nunome K, Miyazaki S, Nakano M, Iguchi-Ariga S, Ariga H (2008) Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1. Biol Pharm Bull 31(7):1321–1326
18. Ohwada K, Takeda H, Yamazaki M, Isogai H, Nakano M, Shimomura M, Fukui K, Urano S (2008) Pyrroloquinoline quinone (PQQ) prevents cognitive deficit caused by oxidative stress in rats. J Clin Biochem Nutr 42:29–34
19. Pandya CD, Howell KR, Pillai A (2013) Antioxidants as potential therapeutics for neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 46:214–223
20. Park G, Park YJ, Yang HO, Oh MS (2013) Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism. Pharmacol Biochem Behav 104:163–168
21. Sanchez RM, Wang C, Gardner G, Orlando L, Tauck DL, Rosenberg PA, Aizenman E, Jensen FE (2000) Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures. J Neurosci 20(6):2409–2417
22. Scanlon JM, Aizenman E, Reynolds IJ (1997) Effects of pyrroloquinoline quinone on glutamate-induced production of reactive oxygen species in neurons. Eur J Pharmacol 326(1):67–74
23. Sharp F, Liu DZ, Zhan X, Ander BP (2008) Intracerebral hemorrhage injury mechanisms: glutamate neurotoxicity, thrombin, and Src. Acta Neurochir Suppl 105:43–46
24. Singh AK, Pandey SK, Naresh Kumar G (2014) Pyrroloquinoline quinone-secreting probiotic Escherichia coli Nissle 1917 ameliorates ethanol-induced oxidative damage and hyperlipidemia in rats. Alcohol Clin Exp Res 38(7):2127–2137
25. Stites TE, Mitchell AE, Rucker RB (2000) Physiological importance of quinoenzymes and the O-quinone family of cofactors. J Nutr 130(4):719–727
26. Sukumari-Ramesh S, Alleyne CH Jr, Dhandapani KM (2012) Astrocyte-specific expression of survivin after intracerebral hemorrhage in mice: a possible role in reactive gliosis? J Neurotrauma 29(18):2798–2804
27. Tang J, Liu J, Zhou C, Alexander JS, Nanda A, Granger DN, Zhang JH (2004) Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice. J Cereb Blood Flow Metab 24(10):1133–1145
28. Tao R, Karliner JS, Simonis U, Zheng J, Zhang J, Honbo N, Alano CC (2007) Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytes. Biochem Biophys Res Commun 363(2):257–262
29. Thomas RR, Khan SM, Portell FR, Smigrodzki RM, Bennett JP Jr (2011) Recombinant human mitochondrial transcription factor A stimulates mitochondrial biogenesis and ATP synthesis, improves motor function after MPTP, reduces oxidative stress and increases survival after endotoxin. Mitochondrion 11(1):108–118
30. Watanabe A, Hobara N, Ohsawa T, Higashi T, Tsuji T (1989) Nephrotoxicity of pyrroloquinoline quinone in rats. Hiroshima J Med Sci 38(1):49–51
31. Wu J, Yang S, Xi G, Song S, Fu G, Keep RF, Hua Y (2008) Microglial activation and brain injury after intracerebral hemorrhage. Acta Neurochir Suppl 105:59–65
32. Xi G, Keep RF, Hoff JT (2002) Pathophysiology of brain edema formation. Neurosurg Clin N Am 13(3):371–383
33. Yamaguchi K, Sasano A, Urakami T, Tsuji T, Kondo K (1993) Stimulation of nerve growth factor production by pyrroloquinoline quinone and its derivatives in vitro and in vivo. Biosci Biotechnol Biochem 57(7):1231–1233
34. Yamaguchi K, Tsuji T, Uemura D, Kondo K (1996) Cyclooxygenase induction is essential for NGF synthesis enhancement by NGF inducers in L-M cells. Biosci Biotechnol Biochem 60(1):92–94
35. Yang Z, Yu A, Liu Y, Shen H, Lin C, Lin L, Wang S, Yuan B (2014) Regulatory T cells inhibit microglia activation and protect against inflammatory injury in intracerebral hemorrhage. Int Immunopharmacol 22(2):522–525
36. Zha H, Reed JC (1997) Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells. J Biol Chem 272(50):31482–31488
37. Zhang Y, Feustel PJ, Kimelberg HK (2006) Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat. Brain Res 1094(1):200–206
38. Zhang P, Xu Y, Sun J, Li X, Wang L, Jin L (2009) Protection of pyrroloquinoline quinone against methylmercury-induced neurotoxicity via reducing oxidative stress. Free Radic Res 43(3):224–233
39. Zhang Q, Shen M, Ding M, Shen D, Ding F (2011) The neuroprotective action of pyrroloquinoline quinone against glutamate-induced apoptosis in hippocampal neurons is mediated through the activation of PI3 K/Akt pathway. Toxicol Appl Pharmacol 252(1):62–72
40. Zhang L, Liu J, Cheng C, Yuan Y, Yu B, Shen A, Yan M (2012) The neuroprotective effect of pyrroloquinoline quinone on traumatic brain injury. J Neurotrauma 29(5):851–864
41. Zhao X, Sun G, Zhang J, Strong R, Song W, Gonzales N, Grotta JC, Aronowski J (2007) Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol 61(4):352–362
42. Zhao X, Grotta J, Gonzales N, Aronowski J (2009) Hematoma resolution as a therapeutic target: the role of microglia/macrophages. Stroke 40(3 Suppl):S92–S94
43. Zhou X, Chen Q, Hu X, Mao S, Kong Y (2014) Pyrroloquinoline quinone prevents MK-801-induced stereotypical behavior and cognitive deficits in mice. Behav Brain Res 258:153–159